Shendelman Shoshana
President and CEO at Applied Therapeutics, Inc.
- Sold, on record
- $15M
- Dollars the filings state
- Form 4 sales
- 9
- Latest Aug 14, 2024
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Applied Therapeutics, Inc.President and CEO
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Applied Therapeutics, Inc.Plan not statedJul 22 2020
Sold 45,000 shares at $26.68 ($1.2M)
Shendelman Shoshana, President and CEO
Sold 7.5% of holdings ($16M position)554,285 shares leftFiling
- 2 Form 4 sale Applied Therapeutics, Inc.Plan not statedJan 11 +903 days
Sold 15,870 shares at $0.91 ($14k)
Shendelman Shoshana, President and CEO
Sold 2.1% of holdings ($698k position)751,625 shares leftFirst sale on recordFiling
- 3 Form 4 sale Applied Therapeutics, Inc.No planSep 27 +259 days
Sold 115,632 shares at $2.70 ($312k)
Shendelman Shoshana, President and CEO
No 10b5-1 planSold 4.3% of holdings ($7.3M position)2.6M shares leftFiling
- 4 Form 4 sale Applied Therapeutics, Inc.No planNov 30 +64 days
Sold 3,968 shares at $1.97 ($8k)
Shendelman Shoshana, President and CEO
No 10b5-1 planSold 0.2% of holdings ($5.1M position)2.6M shares leftFiling
- 5 Form 4 sale Applied Therapeutics, Inc.UnusualMar 14 +105 days
Sold 318,573 shares at $5.39 ($1.7M)
Shendelman Shoshana, President and CEO
No 10b5-1 planSold 7.7% of holdings ($22.3M position)3.8M shares left20.1x usual sizeFiling
- 6 Form 4 sale Applied Therapeutics, Inc.No planJun 6 +84 days
Sold 61,795 shares at $4.32 ($267k)
Shendelman Shoshana, President and CEO
No 10b5-1 planSold 1.6% of holdings ($16.5M position)3.8M shares left0.9x usual sizeFiling
- 7 Form 144 notice Applied Therapeutics, Inc.NoticeAug 9 +64 days
Filed to sell 1M shares ($6.2M)
Shendelman Shoshana, Officer, President and Chief Executive Officer
No 10b5-1 plan16.2x usual sizeFiling
- 8 Form 4 sale Applied Therapeutics, Inc.UnusualAug 14 +5 days
Sold 777,014 shares at $6.06 ($4.7M)
Shendelman Shoshana, President and CEO
No 10b5-1 planSold 14.2% of holdings ($33.2M position)4.7M shares left12.6x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (10)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2024 | Applied Therapeutics, Inc. | President and CEO | Form 4 sale | 777,014 | $4.7M | 14.2% | Unusual | SEC |
| Aug 9, 2024 | Applied Therapeutics, Inc. | Officer, President and Chief Executive Officer | Form 144 notice | 1M | $6.2M | Notice | SEC | |
| Jun 6, 2024 | Applied Therapeutics, Inc. | President and CEO | Form 4 sale | 61,795 | $267k | 1.6% | No plan | SEC |
| Mar 14, 2024 | Applied Therapeutics, Inc. | President and CEO | Form 4 sale | 318,573 | $1.7M | 7.7% | Unusual | SEC |
| Nov 30, 2023 | Applied Therapeutics, Inc. | President and CEO | Form 4 sale | 3,968 | $8k | 0.2% | No plan | SEC |
| Sep 27, 2023 | Applied Therapeutics, Inc. | President and CEO | Form 4 sale | 115,632 | $312k | 4.3% | No plan | SEC |
| Jan 11, 2023 | Applied Therapeutics, Inc. | President and CEO | Form 4 sale | 15,870 | $14k | 2.1% | Plan not stated | SEC |
| Jul 22, 2020 | Applied Therapeutics, Inc. | President and CEO | Form 4 sale | 45,000 | $1.2M | 7.5% | Plan not stated | SEC |
| Jul 9, 2020 | Applied Therapeutics, Inc. | President and CEO | Form 4 sale | 45,000 | $1.4M | 7.5% | Plan not stated | SEC |
| May 28, 2020 | Applied Therapeutics, Inc. | President and CEO | Form 4 sale | 125,000 | $5.3M | 18.4% | Plan not stated | SEC |